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Abstract
Non-communicable diseases (NCDs) are the leading causes of death worldwide, with higher rates 
of premature mortality in low- and middle-income countries (LMICs). This places a high 
economic burden on these countries, which usually have limited capacity to address this public 
health problem. We developed a guided self-assessment tool for describing national capacity for 
NCD prevention and control. The purpose of this tool was to assist countries in identifying key 
opportunities and gaps in NCD capacity. It was piloted in three countries between 2012 and 2013: 
Mozambique, Colombia, and the Dominican Republic. The tool includes details about NCD 
burden; health system infrastructure and primary care services; workforce capacity; surveillance; 
planning, policy, and program management; and partnerships. In the three pilot countries, the tool 
helped to identify differences in capacity needs pertaining to staff, training, and surveillance, but 
similarities were also found related to NCD challenges and opportunities. The NCD tool increased 
our understanding of needs and critical capacity elements for addressing NCDs in the three pilot 
countries. This tool can be used by other LMICs to map their efforts toward addressing NCD goals 
and defining priorities.
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Introduction
In 2012, there were 38 million deaths worldwide (68% of all deaths) due to non-
communicable diseases (NCDs), which include cardiovascular disease, cancer, diabetes, and 
chronic respiratory diseases (1). Approximately 40% of NCD deaths occurred prematurely 
(i.e. before the age of 70); thus, during the most productive years of life. Almost 80% of the 
global NCD mortality occurred in low- and middle-income countries (LMICs) where 
resources and capacity are scarce (1). The Global Burden of Disease study showed an 
increase of approximately 8 million more deaths due to NCDs between 1990 and 2010, 
equivalent to a 30% change, or two out of every three deaths worldwide in 2010 (2). The 
main causes of NCDs are preventable and include behavioral (poor diet and physical 
activity, tobacco use, excessive alcohol consumption) and biologic (overweight and obesity, 
hypertension, raised blood lipids and glucose) risk factors (3). The consequences of NCDs 
place a large burden on governments, health systems, and individuals, especially in resource-
constrained countries. According to a report by the world economic forum (4), by the year 
2030, NCDs will cost approximately US$30 trillion globally, which represents almost 75% 
of the global gross domestic product (GDP) in 2010.
In September 2011, the United Nations (UN) held a High-Level Meeting on NCDs (5), 
which brought together leaders from around the world to highlight NCDs in the global 
development agenda and adopted a resolution that calls for international collaboration, 
including the need to build capacity for NCDs, especially in LMICs (6). With the UN 
declaration and the strong political momentum, the World Health Organization (WHO) 
developed the 2012 Global Action Plan for the prevention and control of NCDs (7), which 
includes indicators and voluntary targets that focus on achieving a global goal of a 25% 
reduction in premature mortality from NCDs by 2025 (also known as the 25x25 target) (8). 
Two of the six WHO objectives of this framework are related directly to strengthening 
national capacity for the management and control of NCDs. Due to the recent NCD global 
response, the US Centers for Disease Control and Prevention’s (CDC) global technical 
assistance expanded to target NCDs specifically in LMICs, with a focus on increasing 
epidemiologic and surveillance capacity and strengthening healthcare systems.
Assessing and building global NCD capacity, especially in LMICs, has been challenging 
(9,10). Capacity may be defined as an ability to perform (11), financial, economic, or 
political capacity (12), knowledge or technical ability (12), and even institutional or 
organizational capacity (13). Efforts to measure capacity have been documented within a 
series of tools and measures, particularly at the system level (14). Some capacity surveys 
and evaluations have been performed with different sets of indicators and objectives, such as 
the WHO global survey to assess country capacity for NCDs (15), as well as some regional 
surveys in Asia (16) and the Pacific Islands (17). In addition, a capacity survey for NCD 
surveillance for the Americas was conducted by the Pan-American Health Organization 
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(PAHO) (18), and at the local/state level the Sustainability Tools for Assessing and Rating 
(STAR) Communities survey in the US was conducted by the National Association of 
Chronic Disease Directors (NACCD) (19). These assessments have been helpful for 
planning and implementation purposes, strengthening ongoing efforts, and increasing 
collaboration (16). However, it is important to acknowledge that health capacity challenges 
are not straightforward, especially in LMICs where there is a large degree of heterogeneity. 
Strengthening capacity for NCDs in LMICs requires understanding of the complex financial, 
infrastructure, human, and institutional conditions in a country (20). Additionally, the burden 
and causes of NCDs vary among LMICs (21).
With the WHO 25x25 target framework and CDC’s global NCD focus, we developed an 
assessment tool (NCD tool) to present a comprehensive and objective evaluation of a 
country’s capacity in the following areas: health system infrastructure; primary care 
services; workforce capacity; surveillance; planning, policy, and program management; and 
partnerships. In this paper we describe the rationale, methodology, and pilot testing of this 




The NCD tool was developed to help respond to technical assistance requests, and was 
intended to be a guided self-assessment, facilitating the process of consultation between the 
CDC and in-country public health stakeholders. The NCD tool is designed to exchange the 
most current information available regarding the country’s NCD capacity with the CDC and 
other partners. These data can be used by each country to identify gaps and strengths in 
areas such as training for NCDs, surveillance, planning, program management, policies, and 
partnerships.
The specific objectives of the tool are to: (i) build a comprehensive profile to better 
understand current national capacity for NCD prevention and control; (ii) assist the country 
to identify key opportunities, priorities, and gaps in capacity; and (iii) strengthen the 
technical assistance process and collaborations between the CDC, the country’s Ministry of 
Health (MOH), and additional partners.
In order to develop the NCD tool, a literature review was conducted in August 2011 to 
identify scientific papers, reports, and expert opinion for assessing health system capacity in 
NCDs. Subsequently, the NCD tool was developed based on this review and the WHO NCD 
monitoring framework (22). The development of the tool was an iterative process and 
included feedback from in-country interviewees to enhance ease of administration, increase 
relevance, and reduce respondent burden.
Topics covered by the tool
The framework for the NCD tool included the following sections: (i) Demographics and 
NCD burden; (ii) Health system infrastructure and primary care services; (iii) Workforce 
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capacity building; (iv) Surveillance and health information; (v) Planning, policy, and 
program management; and (vi) Partnerships.
The NCD tool covered the public health system and primary care services by including 
questions about the type of healthcare system, the organization of NCD control departments 
in the country, and specific budget and resource allocation for NCDs. In terms of data 
available, the tool addressed questions related to vital statistics and civil registration, 
surveillance systems in place related to NCDs and its risk factors, and how the data are 
processed and managed. In terms of workforce, the tool helped us to assess the availability 
of trained individuals working with NCDs and the availability of training mechanisms and 
links with other academic institutions for training MOH staff (e.g. Field Epidemiology 
Training Program) (23). For planning policy and programs, the tool includes questions 
regarding a national NCD strategic plan, which topic areas the plan covers (e.g. diabetes, 
cancer, cardiovascular disease, and chronic pulmonary disease), and the risk factors 
associated with each topic area. The tool also includes questions on the availability of 
national guidelines for the prevention and treatment of NCDs, as well as the availability of 
prevention programs and policies for tobacco, alcohol control, hypertension, nutrition, 
physical activity, and road traffic injury. Finally, the tool allowed us to evaluate the cross-
collaboration and formal partnerships the MOH might have with other stakeholders, such as 
Non-Governmental Organizations (NGOs), academia, the private sector, and multilateral and 
regional partnerships.
The NCD tool can be completed by more than one person or organization because it covers 
several areas. The tool consists of two parts (Figure 1). The first part is the in-house pre-
assessment, which consists of local data review and preparation, and the identification of 
NCD-specific points of contact in relevant public and private organizations. The tool is 
completed several weeks in advance of a technical assistance field visit, enabling local staff 
to get acquainted with the topics covered in the tool and to schedule time for meetings with 
appropriate subject matter experts to discuss topics covered in the tool.
The second part is the in-country assessment, which consists of a series of face-to-face 
meetings between the technical assistance team and in-country partners, as well as a final 
debrief and report sent out to the country with specific follow-up activities for CDC staff 
and/or country stakeholders. By including objective assessments (surveillance data and 
reports) and more qualitative data (face-to-face interviews and briefings), the tool provides a 
comprehensive perspective on how NCD prevention and control is structured in the country.
Implementation and dissemination
The information for the first part of the NCD tool was obtained through literature searches 
from web documents and online databases (e.g. WHO Global Infobase, CIA World 
Factbook, or surveillance reports posted online, including International Cancer Registries, 
Global Tobacco Surveys, and Demographic Health Surveys). For the second part of the tool, 
the country point of contact verified the accuracy and relevance of the data and additional 
information was obtained during face-to-face interviews. In 2012, the Global Health 
Promotion Office in the National Center for Chronic Disease Prevention and Health 
Promotion piloted the tool to prepare for providing technical assistance in Mozambique, 
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Colombia, and the Dominican Republic. These three countries were selected for the pilot 
based on ongoing collaboration between CDC and the country; a specific request for 
technical assistance; willingness from the country to collaborate; and geographic diversity 
(Africa, South America, and the Caribbean). The tool was translated into Spanish and 
Portuguese where necessary, and interviews in Colombia and the Dominican Republic were 
conducted in Spanish by native speakers. The interview in Mozambique was conducted in 
both English and Portuguese.
After receiving the self-guided portion of the NCD tool from the point of contact in each 
country, interviews with key informants were held between March and September 2012. 
These key informants were identified and selected prior to the field visit by the local point of 
contact from the MOH’s NCD unit or equivalent office. Additionally, we met with other 
important NCD stakeholders in each country, ranging from the Ministry of Education, 
Ministry of Sports (or equivalent), Institute of Public Health, NGOs (e.g. Diabetes 
Association in Mozambique and Population Services International (PSI) in Dominican 
Republic), international agencies (e.g. Pan-American Health Organization in the Dominican 
Republic), hospitals, foundations, academic institutions, and independent researchers. This 
tool was developed to be used by other researchers and practitioners in order to further 
evaluate capacity in LMIC countries and aid the process of providing NCD technical 
assistance. The tool can be downloaded from the Emory Global Diabetes Research Center 
(EGDRC) website, a unit within the Rollins School of Public Health, Hubert Department of 
Global Health, at Emory University.i
Results
NCD assessment tool pilots
Table 1 provides a summary of some of the information that was obtained through the NCD 
tool. The results for the assessments showed that even though these three countries are very 
different in terms of geography, population, culture, and readiness to address NCDs, they 
also shared many similarities related to the challenges and opportunities associated with 
NCDs in LMICs. The time it took for part 1 (in-house self-guided assessment) was 
approximately one month, including the collection of data, identifying the point of 
contact(s), having the online tool answered, and collecting background documents. For the 
second part, the face-to-face interviews, meetings with different stakeholders, and the final 
in-country debrief, 3–4 days were required (Colombia and the Dominican Republic: 4 
meeting days; Mozambique: 3 meeting days) and the final report to the country was sent one 
month later.
NCD burden
The data obtained by the tool revealed that even when the burden of communicable diseases 
(notably HIV, malaria, and tuberculosis) remains high, NCDs already account for a 
significant percentage of mortality (cardiovascular disease, stroke, cancer, diabetes,and 
iFor review and dissemination purposes, the NCD tool is posted at the EGDRC within the Emory School of Public Health website: 
http://diabetes.emory.edu/capacity%20building/NCD%20Country%20Capacity%20Assessment%20Tools.html
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injury) in these LMICs.In Mozambique, chronic conditions are rising rapidly; for example, 
in 2004, NCDs accounted for 26% of all deaths reported, but more recent estimates indicate 
that mortality for NCDs is now as high as 40%. At the time of the assessment, in the 
Dominican Republic and Colombia, the deaths attributable to NCDs were 68% and 66%, 
respectively.
Health system infrastructure
Piloting in these three countries revealed that even though there are differences in terms of 
the complexity of the organization, they all had a dedicated department for NCDs housed in 
the MOH. The NCD department in each country had different capacities. For example, 
Mozambique’s MOH has a small NCD unit with limited staff (one NCD director) created in 
2002, whereas the Dominican Republic has a medium-sized NCD program sitting under the 
vice MOH National Program for Prevention of Chronic Diseases (PRONECEC), with three 
staff hired since 2010. In contrast, Colombia has a more comprehensive and complex 
structure with many partners and stakeholders working on NCDs, ranging from the National 
Institute of Public Health (INS), the Sub-directorate of NCDs in the MOH, the Ministry of 
Sports (Coldeportes), several academic, scientific, and medical societies and research 
institutions, and think tanks. As for the provision and coverage of healthcare services, 
Mozambique has a predominantly public sector, and the healthcare system is structured in 
four levels: 1) primary healthcare clinics and health posts; 2) district level hospitals; 3) 
provincial level hospitals; and 4) central level hospitals (three main central hospitals in the 
country). The Dominican Republic’s NCD unit (PRONECEC) works in coordination with 
the regional health services, which are divided into three levels of care: primary (health 
clinics), secondary (provincial hospitals – about 1700 in the country), and tertiary (reference 
hospitals). Health services coverage is both public and private, having a mix of subsidized 
and private insurance regimes for healthcare services. In Colombia, healthcare services are 
provided by 69 entities that act as health insurers, and can be public or private and provide 
services offered by the mandatory national health plan.
Workforce capacity
The tool helped identify some strengths and weaknesses within the MOH related to training 
and capacity building for NCDs. The workforce performance reported is good and in most 
cases there are sufficient trainings and opportunities for professional growth. However, most 
of the staff are contractors, which makes it hard to strengthen some work groups and ensure 
the continuity of NCD activities and programs. The disciplines working within the NCD 
units varied greatly and we found very different professional profiles including: public 
health, medicine, biostatistics, epidemiology, psychology, nutrition, nursing, pedagogy, 
economy, political sciences, demography, administration, and communication, with some 
staff having graduate degrees such as an Master in Public Health (MPH) and very few with 
doctoral degrees or above. In summary, NCD workforce was identified as a challenge, in 
part, because of the limited number of staff within the MOH to address NCDs and lack of 
stability for employees; many staff are temporary contractors with few full-time employees, 
resulting in high staff turnover.
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NCD surveillance, prevention, and control activities are being implemented with some 
success but we found through the interviews that this area is quite limited by funding. In 
terms of NCD surveillance, the results show that data are available for most of the NCDs 
and risk factors; however, some of the data are either not collected periodically or recently, 
or results are not publicly available. For example, in Colombia data for NCDs and risk 
factors are collected periodically through two national surveys (National Nutrition Survey 
(ENSIN) and National Health Survey (ENS). The Dominican Republic and Mozambique 
have performed surveys that include risk factors like obesity, tobacco consumption, or 
alcohol use. Additionally, Mozambique has a population cancer registry in the city of Beira 
along with an injury hospital registry in Maputo – the capital’s central hospital. For each 
country, there was a consistent lack of funding and clear needs for training in surveillance, 
program management, and evaluation.
Discussion
Overall, the use of the NCD tool provides a profile of the readiness of each piloted country 
to address NCDs. Specifically, the NCD tool helped us to understand in greater depth the 
NCD burden and data availability, health system capacity, human and financial resources, 
deployment of interventions, policy development and implementation, and main NCD 
players in each of the countries. The profile created by the tool was used to assist the 
countries to identify needs, opportunities, and priorities, while strengthening capacity-
building efforts between the CDC, MOHs, and regional partners. NCDs have a very broad 
spectrum, and gaps and strengths in one country or region might not translate to others. The 
structured approach for assessing NCD capacity across several domains seems to aid in 
identifying and prioritizing different areas for capacity building and follow-up.
Piloting the tool increased awareness of cross-collaboration within the MOH, the CDC and 
of other key partners working on NCDs in the country. Incorporating multi-sectoral 
approaches has helped to build capacity and build on existing infrastructure (24). The MOH 
recognized that there was a lot of overlap in efforts to address NCDs; however, cross-
collaboration and communication could improve the NCD work done in each country. The 
NCD tool can help to increase and foster relationships inside and outside the government 
and throughout topic areas. The overall process can also help stakeholders to think about 
topic areas and partners not previously considered in the NCD arena, such as a collaboration 
between NCDs and communicable diseases, especially in lower income countries which are 
still struggling with diseases such as HIV, Tuberculosis, or Malaria but are also affected with 
NCDs (25,26). The process also helped to plan ahead for gaps in capacity, as some of the 
countries didn’t have a complete overview of NCD national capacity.
The findings also reveal that capacity for NCDs is still in its early stages, especially in 
Mozambique and the Dominican Republic where infectious diseases like HIV comprise a 
significant portion of the health agenda. However, we found through the interviews that after 
the UN NCD summit (5) and with the WHO 25×25 framework (7), government leaders have 
been paying more attention to NCDs and trying to increase resource allocation for NCDs. It 
is important to note that the assessments took place in 2012 and some things have changed 
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since then; after the pilot assessment in Mozambique took place in 2012, the NCD unit 
moved to the Mozambique National Public Health Institute in 2014 and has increased in size 
to include the NCD director and three public health staff. The NCD tool facilitated the 
identification of financial resources as a barrier for all the countries assessed, coinciding 
with previous research done on NCD capacity (27). For example, a common barrier 
identified for surveillance and data collection by the three pilot countries is the need for 
external funders (e.g. CDC and WHO) to provide financial resources and training. Financial 
resources and political will were common constraints. This aligns with the traditional model 
of international aid (10) and underscores the importance of building sustainability into the 
technical assistance process.
Human resource capacity and lack of training were also identified as common challenges. 
Specifically, the availability of a trained and knowledgeable workforce to address NCDs has 
been a challenge; in many cases the internal processes make it hard to hire full-time health 
staff and, in turn, the MOH must depend on contractors or temporary staff. This issue, along 
with low wages and insufficient training, is one that many LMICs face (28); however, other 
stakeholders and institutes within the government, private sector, and non-profit sector may 
be able to partner and join forces with the NCD department to address NCDs and risk 
factors. We also learned through the interviews that while countries have identified priorities 
through a specific framework and strategic plan to address NCDs, there is still a gap between 
policy and implementation. NCD plans and frameworks exist, but often they are not 
executed due to financial constraints, lack of staff, or a lack of implementation capability. 
Additionally, and in-line with some reviews (29,30), it is important for the availability of 
data and high-quality scientific literature to come from the LMIC where the mortality 
burden is greatest. A mentoring system and partnering with neighbor countries could be 
viable solutions to address this gap. Additionally, as some authors have suggested 
(25,31,32), encouraging and investing in high-quality research and capacity building in 
LMICs can be translated into great examples of good practice, not only in LMICs but also in 
developed countries.
Surveillance for NCDs and its risk factors was at different development stages in all three 
countries, but remains a challenge in all three countries due to a lack of financial and human 
resources. The goal of ongoing periodic data collection is potentially burdensome and not 
yet a reality. This is of special concern as strong monitoring frameworks need to be in place 
to assess progress towards the WHO 25×25 targets and achieve the goal of a 25% reduction 
in premature mortality by 2025. Surveillance data could help direct and prioritize efforts, 
which, in turn, might enhance accountability for monitoring progress.
Some limitations of the tool were that it is not 100% comprehensive for all NCDs or all 
capacity areas, due to potential respondent burden. Additionally, while the in-house 
collection of data helped to gauge NCD burden, data available to outside stakeholders were 
typically not up to date and required updating during the interview.
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The information gathered using the NCD tool facilitated understanding of how to address 
technical assistance needs for NCDs and the critical capacity elements for moving forward 
with NCD prevention in each of the three countries. The results from the tool can be used as 
a bi-directional way of communication between the CDC and other groups providing 
technical assistance and countries in identifying needs and opportunities and strengthening 
capacity-building efforts. The process of developing and piloting the NCD tool clearly 
demonstrated the value of an instrument for systematically measuring national NCD 
capacity. This tool has the potential to be used by other LMICs to guide and prioritize their 
efforts to address NCDs. Additionally, the process of measuring NCD capacity stimulated a 
productive discussion within the three pilot countries and increased awareness of neglected 
areas and non-traditional partners that might have not been contemplated in a traditional 
framework.
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Table 1
Summary of results from piloting of the NCD assessment tool in Colombia, the Dominican Republic, and 
Mozambique.












NCD sub-directorate nested in the 
MOH working
with National Institute of Public Health 
(INS)
98% coverage: 53% in the subsidized 
regime,
40% in the contributive, the rest (2.3%) 
affiliated
to the military, Ecopetrol, or police. 
4.4% are not
affiliated (2010)
NCD program nested in the MOH 
created
in 2010
52% coverage (2012) through the Plan
Basico de Salud. Contributive 53.7% 
and
subsidized 45.7%
NCD Unit (DDNT) 
within the MOH
(created in 2002) working 
mostly with
academic partners






Health sector is structured through 
'Promoting
Health Entities' (Entidades Promotoras 
de Salud)
which offer services through health 
insurance
plans according to the 'Mandatory 
Health Plan'
Divided into three levels of care: 
primary
(health clinics), secondary (provincial
hospitals), and tertiary (reference
hospitals)
Structured in four levels: 
primary










Complex system that integrates 
information from
various databases: the Unique Registry 
for Social
Security (RUAF) and the Individual 
Registry for
health care services (RIPS) 
(information provided
by insurance companies). Additionally, 
the
National Statistics Department (DANE) 
compiles
the information and analyzes it along 
with the
National Institute of Public Health
There is no formal surveillance system 
in
place, most information obtained by
independent surveys
The Department of 
Health Information






Mortality information for 
Cardiovascular disease
(CVD), Cancer, Diabetes, Chronic 
Obstructive
Pulmonary Disease (COPD), and injury 
is gathered
and available at a local, department 
(state), and
national level.
There are population cancer registries 
done by
some universities and financed by the 
MOH
through the National Cancer Institute
The mortality data for NCDs available 
is
for cardiovascular disease, cancer, 
diabetes,
COPD, and injury (all at a hospital 
level).
Some information from specific point-
in-
time surveys.
Cancer and renal chronic disease
morbidity data are available from the
primary level of care
Hospital-based cancer 
registry since








2007 National Health Survey: blood 
pressure,
tobacco, diabetes, hyperglycemia, and 
cholesterol.
Periodicity: every five years.
2005 and 2010 National Nutrition 
Survey
(Encuesta Nacional de la situación 
nutricional
(ENSIN)): 2010 version includes 
anthropometry,
biochemical indicators, food security, 
food
frequency, physical activity, TV 
viewing time, and
perception of body image.
2007 National Demographic and 
Health
Survey (ENDESA): tobacco, alcohol,
breastfeeding, self-reported diabetes,
hypertension, cancer, and 
cardiovascular
disease.
2003 World health survey Dominican
Republic: tobacco, alcohol, intake of 
fruit
and vegetables, and physical activity.
1998 and 2008 Risk Factors for
cardiovascular and metabolic 
syndrome in
the Dominican Republic (EFRICARD) 
I/II:
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Area Indicator Colombia Dominican Republic Mozambique
Additionally, there is the Tobacco and 
Alcohol
Survey (ENTAB) based on the Global 
Youth
Tobacco Survey (GYTS) every four 
years available
in some cities
CVD, hypertension, overweight and






MOH: 35 staff members (four 
permanent
positions).
INS: 16 staff members (three 
permanent
positions).
Coldeportes: three staff members.
the Field Epidemiology Training 
Program (FETP)
NCD courses (basic, short and basic 
plus) have
been adapted and piloted in several 
locations, one
FETP in the MOH working on NCDs 
and 11 at
the INS
National Program for Chronic 
Diseases
(PRONCEC) in the Dominican 
Republic
has three staff members.
The head of NCD program is an FETP
graduate. FETP is strong in the 
country
with a strong infectious disease focus
DDNT works with three 
people.
Additionally, two FETPs 
working on
cancer and injury 
projects.
FETP is strong for 
infectious diseases.
NCD basic course was 
taught on 2012
to the NCD local 
coordinators for the




There is extensive collaboration 
between MOH,
INS, and Coldeportes. Additional 
collaboration for
specific projects with the Ministry of 
education,
the National Institute for Food 
Surveillance and
Safety (INVIMA), and several 
universities and
research institutions. The NGO side is 
relatively
weak for NCDs, even though some 
organizations
do some work
Some formal agreements with the
Nutrition Institute for Central America
and Panama (INCAP), the 
Autonomous
University of Santo Domingo and
University of Puerto Rico. 
Partnerships
with NGOs are mostly for infectious
diseases, but PSI is interested in 
engaging
in diabetes, nutrition and physical 
activity
work
Some links with the 
department of
transportation for injury 
prevention.
Also there are linkages 
with maternal
and child health in 
tobacco and alcohol
areas.








Framework document for the 
management of
NCDs is under development





Cancer treatment and comprehensive 
care
guidelines.
CVD guidelines (includes acute 
myocardial
infarction and hypertension).
Diabetes treatment guidelines (under 
review at the
moment).
Physical activity guidelines (technical 
document
from Coldeportes)
PAHO NCD and risk factor guidelines 
are
used for the country.
Available cancer and hypertension




guidelines exist in the 
country
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